STOCK TITAN

[Form 4] PRECIGEN, INC. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4

Randal J. Kirk, a director and 10% owner of Precigen, Inc. (PGEN), reported multiple transactions in mid-September 2025. On 09/17/2025 the reporting person received 25,000 shares of 8.00% Series A Convertible Perpetual Preferred Stock sold in a private placement, convertible into 17,385,257 common shares at a conversion mechanism described in the agreement. On 09/18/2025 and 09/19/2025 the reporting person (through entities he controls) sold a total of 5,000,252 common shares: 1,403,360 shares at a weighted average price of $3.86 and 3,596,892 shares at a weighted average price of $3.68. The filing lists multiple entities controlled by Mr. Kirk that hold beneficial ownership interests and disclaims direct beneficial ownership except for pecuniary interest.

Randal J. Kirk, amministratore e 10% proprietario di Precigen, Inc. (PGEN), ha riportato diverse operazioni nella metà settembre 2025. Il 17/09/2025 la persona segnalante ha ricevuto 25.000 azioni di Azioni Preferenziali Perpetue Convertibili di Serie A con tasso 8,00%, vendute in una collocazione privata, convertibili in 17.385.257 azioni ordinarie secondo un meccanismo di conversione descritto nell'accordo. Il 18/09/2025 e il 19/09/2025 la persona segnalante (attraverso entità da lui controllate) ha venduto in totale 5.000.252 azioni ordinarie: 1.403.360 azioni a prezzo medio ponderato di $3,86 e 3.596.892 azioni a prezzo medio ponderato di $3,68. La relazione cita diverse entità controllate dal Sig. Kirk che possiedono interessi di proprietà beneficiaria e respinge la proprietà beneficiaria diretta, salvo l'interesse pecuniario.

Randal J. Kirk, director y titular del 10% de Precigen, Inc. (PGEN), informó de varias operaciones a mediados de septiembre de 2025. El 17/09/2025 la persona que reporta recibió 25.000 acciones de Acciones Preferentes Perpetuas Convertibles de Serie A con 8,00% vendidas en una colocación privada, convertibles en 17.385.257 acciones ordinarias según un mecanismo de conversión descrito en el acuerdo. El 18/09/2025 y el 19/09/2025 la persona reportante (a través de entidades bajo su control) vendió un total de 5.000.252 acciones ordinarias: 1.403.360 a un precio medio ponderado de $3,86 y 3.596.892 a un precio medio ponderado de $3,68. La presentación lista varias entidades controladas por el Sr. Kirk que poseen intereses de propiedad beneficiosa y excluye la propiedad beneficiosa directa, salvo por interés pecuniario.

랜달 J. 커크, Precigen, Inc. (PGEN)의 이사이자 10% 지분 보유자는 2025년 9월 중순에 다수의 거래를 보고했다. 2025년 9월 17일 보고자는 비공개 배정으로 매각된 8.00% 시리즈 A 가변 영구 우선주 25,000주를 받았고, 협약에 설명된 전환 메커니즘에 따라 17,385,257주를 보통주로 전환할 수 있다. 2025년 9월 18일 및 9월 19일에 보고자(그가 지배하는 법인을 통해)는 총 5,000,252주의 보통주를 매도했다: 1,403,360주를 가중평균가 $3.86로, 3,596,892주를 가중평균가 $3.68로 매도. 제출서는 커크 씨가 지배하는 다수의 법인이 실질적 소유권을 보유하고 있다고 기재하며, 직접적 실질 소유권은 부인하고 다만 금전적 이해관계는 예외로 한다고 명시합니다.

Randal J. Kirk, administrateur et titulaire de 10 % de Precigen, Inc. (PGEN), a signalé plusieurs transactions à la mi-septembre 2025. Le 17/09/2025, la personne déclarant a reçu 25 000 actions d'actions privilégiées convertibles perpétuelles de série A à 8,00 %, vendues lors d'une placement privé, convertibles en 17 385 257 actions ordinaires selon un mécanisme de conversion décrit dans l'accord. Le 18/09/2025 et le 19/09/2025, la personne déclarant (par le biais d'entités qu'il contrôle) a vendu un total de 5 000 252 actions ordinaires : 1 403 360 à un prix moyen pondéré de 3,86 $ et 3 596 892 à un prix moyen pondéré de 3,68 $. Le dossier répertorie plusieurs entités contrôlées par M. Kirk qui détiennent des droits de propriété bénéficiaire et déclare renoncer à la propriété bénéficiaire directe, à l'exception d'un intérêt pécuniaire.

Randal J. Kirk, Direktor und 10 %-Eigentümer von Precigen, Inc. (PGEN), meldete Mitte September 2025 mehrere Transaktionen. Am 17.09.2025 erhielt die meldende Person 25.000 Aktien von 8,00 % Serie A wandelbare perpetuelle Vorzugsaktien, die in einer privaten Platzierung verkauft wurden, und gemäß einem im Abkommen beschriebenen Umwandlungsmechanismus in 17.385.257 Stammaktien umgewandelt werden können. Am 18.09.2025 und 19.09.2025 verkaufte die meldende Person (durch von ihr kontrollierte Einheiten) insgesamt 5.000.252 Stammaktien: 1.403.360 Aktien zu einem gewogenen Durchschnittspreis von 3,86 $ und 3.596.892 Aktien zu einem gewogenen Durchschnittspreis von 3,68 $. Die Einreichung listet mehrere von Herrn Kirk kontrollierte Einheiten auf, die wirtschaftliche Eigentumsrechte halten, und bestreitet direktes wirtschaftliches Eigentum, außer einem monetären Interesse.

رانالد ج. كيرك، مدير ومالك 10% من Precigen, Inc. (PGEN)، أبلغ عن عدة معاملات في منتصف سبتمبر 2025. في 17/09/2025 تلقّت الشخص المبلّغ عنه 25,000 سهم من الأسهم الممتازة القابلة للتحويل إلى مدى الحياة من الفئة أ بنسبة 8.00%، تم بيعها في طرح خاص، وقابلة للتحويل إلى 17,385,257 سهمًا عاديًا وفق آلية التحويل الواردة في الاتفاق. في 18/09/2025 و19/09/2025 باع الشخص المبلغ عنه (من خلال كيانات يسيطر عليها) إجمالًا 5,000,252 سهمًا عاديًا: 1,403,360 سهمًا بسعر وسطي مُثقل قدره 3.86 دولار و3,596,892 سهمًا بسعر وسطي مُثقل قدره 3.68 دولار. تُشير المذكرة إلى عدة كيانات يسيطر عليها السيد كيرك تملك مصالح ملكية مفيدة وتتنصل من الملكية المفيدة المباشرة باستثناء مصلحة مادية.

兰达尔 J. 柯克,Precigen, Inc.(PGEN)的董事兼10%股东,于2025年9月中旬报告了多项交易。 2025/09/17,报告人收到在私募发行中成交的8.00% A系列可转换永久优先股的25,000股,按协议中的转换机制可转换为17,385,257股普通股。2025/09/18及2025/09/19,报告人(通过其控制的实体)共出售了5,000,252股普通股:1,403,360股,加权平均价为$3.86;3,596,892股,加权平均价为$3.68。提交文件列出由柯克先生控制的多家实体持有受益所有权,并声明不承认直接的受益所有权,除经济利益外。

Positive
  • Conversion event documented: 25,000 shares of 8.00% Series A Convertible Perpetual Preferred Stock converted into 17,385,257 common shares (reported 09/17/2025).
  • Full disclosure of sale prices: Weighted-average sale price ranges provided and offering footnotes commit to provide breakdowns on request.
Negative
  • Significant dispositions: Reported sales of 1,403,360 shares on 09/18/2025 and 3,596,892 shares on 09/19/2025, totaling 5,000,252 shares.
  • Concentrated beneficial ownership: Numerous related entities are listed as holding shares indirectly, which may complicate clear ownership attribution.

Insights

TL;DR: Director Randal J. Kirk converted preferred stock into 17.4M common shares and sold ~5.0M shares across two days.

The Form 4 documents a private-placement conversion event tied to Series A Preferred Stock that resulted in 17,385,257 common shares credited to the R.J. Kirk Declaration of Trust on 09/17/2025, followed by open-market disposition of 1,403,360 shares on 09/18/2025 and 3,596,892 shares on 09/19/2025 at weighted average prices of $3.86 and $3.68, respectively. The disclosure also enumerates numerous affiliated entities through which Mr. Kirk may be deemed to beneficially own shares. For investors monitoring insider activity, this is a material insider conversion plus partial sell-down, fully documented in the filing.

TL;DR: Filing shows a director’s large conversion and subsequent sales; beneficial ownership is held across many related entities.

The report clearly attributes control of multiple entities (e.g., Kapital Joe, Third Security, Sunset 2020) to Randal J. Kirk and lists indirect holdings by each. The form discloses the terms of the Preferred Stock sale from December 27, 2024 and that shareholder approval for conversion was obtained on June 26, 2025. The reporting person explicitly disclaims beneficial ownership beyond pecuniary interest where applicable. This filing adheres to Section 16 reporting requirements and supplies weighted-average sale price ranges in footnotes.

Randal J. Kirk, amministratore e 10% proprietario di Precigen, Inc. (PGEN), ha riportato diverse operazioni nella metà settembre 2025. Il 17/09/2025 la persona segnalante ha ricevuto 25.000 azioni di Azioni Preferenziali Perpetue Convertibili di Serie A con tasso 8,00%, vendute in una collocazione privata, convertibili in 17.385.257 azioni ordinarie secondo un meccanismo di conversione descritto nell'accordo. Il 18/09/2025 e il 19/09/2025 la persona segnalante (attraverso entità da lui controllate) ha venduto in totale 5.000.252 azioni ordinarie: 1.403.360 azioni a prezzo medio ponderato di $3,86 e 3.596.892 azioni a prezzo medio ponderato di $3,68. La relazione cita diverse entità controllate dal Sig. Kirk che possiedono interessi di proprietà beneficiaria e respinge la proprietà beneficiaria diretta, salvo l'interesse pecuniario.

Randal J. Kirk, director y titular del 10% de Precigen, Inc. (PGEN), informó de varias operaciones a mediados de septiembre de 2025. El 17/09/2025 la persona que reporta recibió 25.000 acciones de Acciones Preferentes Perpetuas Convertibles de Serie A con 8,00% vendidas en una colocación privada, convertibles en 17.385.257 acciones ordinarias según un mecanismo de conversión descrito en el acuerdo. El 18/09/2025 y el 19/09/2025 la persona reportante (a través de entidades bajo su control) vendió un total de 5.000.252 acciones ordinarias: 1.403.360 a un precio medio ponderado de $3,86 y 3.596.892 a un precio medio ponderado de $3,68. La presentación lista varias entidades controladas por el Sr. Kirk que poseen intereses de propiedad beneficiosa y excluye la propiedad beneficiosa directa, salvo por interés pecuniario.

랜달 J. 커크, Precigen, Inc. (PGEN)의 이사이자 10% 지분 보유자는 2025년 9월 중순에 다수의 거래를 보고했다. 2025년 9월 17일 보고자는 비공개 배정으로 매각된 8.00% 시리즈 A 가변 영구 우선주 25,000주를 받았고, 협약에 설명된 전환 메커니즘에 따라 17,385,257주를 보통주로 전환할 수 있다. 2025년 9월 18일 및 9월 19일에 보고자(그가 지배하는 법인을 통해)는 총 5,000,252주의 보통주를 매도했다: 1,403,360주를 가중평균가 $3.86로, 3,596,892주를 가중평균가 $3.68로 매도. 제출서는 커크 씨가 지배하는 다수의 법인이 실질적 소유권을 보유하고 있다고 기재하며, 직접적 실질 소유권은 부인하고 다만 금전적 이해관계는 예외로 한다고 명시합니다.

Randal J. Kirk, administrateur et titulaire de 10 % de Precigen, Inc. (PGEN), a signalé plusieurs transactions à la mi-septembre 2025. Le 17/09/2025, la personne déclarant a reçu 25 000 actions d'actions privilégiées convertibles perpétuelles de série A à 8,00 %, vendues lors d'une placement privé, convertibles en 17 385 257 actions ordinaires selon un mécanisme de conversion décrit dans l'accord. Le 18/09/2025 et le 19/09/2025, la personne déclarant (par le biais d'entités qu'il contrôle) a vendu un total de 5 000 252 actions ordinaires : 1 403 360 à un prix moyen pondéré de 3,86 $ et 3 596 892 à un prix moyen pondéré de 3,68 $. Le dossier répertorie plusieurs entités contrôlées par M. Kirk qui détiennent des droits de propriété bénéficiaire et déclare renoncer à la propriété bénéficiaire directe, à l'exception d'un intérêt pécuniaire.

Randal J. Kirk, Direktor und 10 %-Eigentümer von Precigen, Inc. (PGEN), meldete Mitte September 2025 mehrere Transaktionen. Am 17.09.2025 erhielt die meldende Person 25.000 Aktien von 8,00 % Serie A wandelbare perpetuelle Vorzugsaktien, die in einer privaten Platzierung verkauft wurden, und gemäß einem im Abkommen beschriebenen Umwandlungsmechanismus in 17.385.257 Stammaktien umgewandelt werden können. Am 18.09.2025 und 19.09.2025 verkaufte die meldende Person (durch von ihr kontrollierte Einheiten) insgesamt 5.000.252 Stammaktien: 1.403.360 Aktien zu einem gewogenen Durchschnittspreis von 3,86 $ und 3.596.892 Aktien zu einem gewogenen Durchschnittspreis von 3,68 $. Die Einreichung listet mehrere von Herrn Kirk kontrollierte Einheiten auf, die wirtschaftliche Eigentumsrechte halten, und bestreitet direktes wirtschaftliches Eigentum, außer einem monetären Interesse.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KIRK RANDAL J

(Last) (First) (Middle)
C/O THIRD SECURITY, LLC
1881 GROVE AVENUE

(Street)
RADFORD VA 24141

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/17/2025 M 17,385,257(1) A (1) 82,164,767 I by R.J. Kirk DOT(4)
Common Stock 09/18/2025 S 1,403,360 D $3.86(2) 12,117,429 I by Kapital Joe(4)
Common Stock 09/19/2025 S 3,596,892 D $3.68(3) 8,520,537 I by Kapital Joe(4)
Common Stock 1,096,686 I by Parkview 2020(4)
Common Stock 490,401 I by JPK 2008(4)
Common Stock 3,703,398 I by JPK 2009(4)
Common Stock 1,654,363 I by JPK 2012(4)
Common Stock 489,438 I by MGK 2008(4)
Common Stock 3,944,437 I by MGK 2009(4)
Common Stock 1,637,040 I by MGK 2011(4)
Common Stock 578,079 I by ZSK 2008(4)
Common Stock 351,120 I by ZSK 2009(4)
Common Stock 453,731 I by Kellie L. Banks LTT(4)
Common Stock 1,403 I by Lotus(4)
Common Stock 16,406,828 I by Sunset 2020(4)
Common Stock 6,085,471 I by Third Security(4)
Common Stock 1,144,481 I by Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
8.00% Series A Convertible Perpetual Preferred Stock $1.438(1) 09/17/2025 M 25,000 (1) (1) Common Stock 17,385,257(1) (1) 0 I by R.J. Kirk DOT(4)
Explanation of Responses:
1. On December 27, 2024, the issuer entered into a Securities Purchase Agreement with certain existing and new investors, including R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), pursuant to which the issuer agreed to sell its 8.00% Series A Convertible Perpetual Preferred Stock (the "Preferred Stock") in a private placement transaction. The Preferred Stock was convertible into shares of common stock of the issuer (i) at the option of the holder at anytime on or after the later of the six-month anniversary of the issue date and the date on which the issuer has, among other things, obtained shareholder approval, which shareholder approval was obtained on June 26, 2025 and (ii) at an initial conversion price of approximately $1.125 per share, which conversion price was subject to upward adjustment based on the valuation of the common stock from time to time.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.78 to $3.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.63 to $3.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
4. Randal J. Kirk controls each of R.J. Kirk DOT, Kapital Joe, LLC ("Kapital Joe"), Parkview 2020 Limited Partnership ("Parkview 2020"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Lotus Capital (2000) Company, Inc. ("Lotus"), Sunset 2020 LLC ("Sunset 2020") and Third Security, LLC ("Third Security"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
/s/ Randal J. Kirk 09/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Randal J. Kirk report on the PGEN Form 4?

The filing reports receipt on 09/17/2025 of 25,000 Series A Preferred shares convertible into 17,385,257 common shares, and sales of 1,403,360 shares on 09/18/2025 and 3,596,892 shares on 09/19/2025.

At what prices were the reported PGEN share sales executed?

The 09/18/2025 sales had a weighted average price of $3.86 (range $3.78–$3.95) and the 09/19/2025 sales had a weighted average price of $3.68 (range $3.63–$3.79).

Which entities are indicated as holding shares indirectly for Mr. Kirk?

The filing lists affiliated entities including R.J. Kirk DOT, Kapital Joe, Parkview 2020, JPK 2008/2009/2012, MGK 2008/2009/2011, ZSK 2008/2009, Kellie L. Banks LTT, Lotus, Sunset 2020, and Third Security.

Does Mr. Kirk claim direct beneficial ownership of the listed entity holdings?

Mr. Kirk states he controls the listed entities but disclaims beneficial ownership of such shares except to the extent of any pecuniary interest.

When was the Securities Purchase Agreement that created the Preferred Stock executed?

The filing states the Securities Purchase Agreement was entered into on December 27, 2024.
Precigen Inc

NASDAQ:PGEN

PGEN Rankings

PGEN Latest News

PGEN Latest SEC Filings

PGEN Stock Data

1.18B
267.25M
10.47%
66.81%
12.13%
Biotechnology
Pharmaceutical Preparations
Link
United States
GERMANTOWN